] As of Jan. 3 02:10 P.M., Daewon Pharmaceutical increased 2.8%, compared with yesterday, to 22,050 won. It had increased 10.53% through the past month. Standard deviation, the volatility index for stock price, was 1.5% on the same period of time over one month.
Compared with its close competitors within the same industry, KOSPI, the monthly earnings rate of Daewon Pharmaceutical was considerably higher than that of its peer group's, but its volatility with in 1 month was the lowest. Over the recent month, the Return On Risk, the return on investment with consideration about risk, was 7.0. The lowest volatility leads the Return On Risk to its highest level. Moreover, compared with the KOSPI industry, the Return On Risk is much better than the industrial mean, 0.5, and thus the industrial comparison performance was good.
By HeRo (firstname.lastname@example.org
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.